Elysium Basis is the trust pick among the alternatives in this ranking — and the place to start the honesty up front: it's NR plus pterostilbene, not NMN, and we label it that way deliberately. It carries the one credential almost nothing else in this category has: NSF Certified for Sport, a genuine independent certification that verifies contents and screens for banned substances. It's also backed by a placebo-controlled trial showing it raises NAD+, and — like all NR — it sidesteps the FDA's late-2022 NMN exclusion entirely, so it stays reliably in stock rather than vanishing or rotating ASINs. The honest limits are price and product class. At roughly $60 it's a higher monthly cost than most picks here and the 60-capsule bottle is a 30-day supply, so you're paying a premium for the certification and the trial-backed formula. And the NR-plus-pterostilbene formula is a different product class from single-ingredient NMN: NR is a step further back in the NAD+ pathway, and the pterostilbene is a longevity-adjacent polyphenol rather than a proven independent benefit. For a buyer who weights independent certification and reliable availability above getting NMN specifically, Basis is the most-tested, most-stable option in the lineup; for a buyer set on NMN, it's an honest alternative to consider rather than the thing itself.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete NMN guide →The standout axis and the reason Basis ranks where it does. It carries NSF Certified for Sport — a genuine independent certification verifying contents and screening for banned substances, which is rare in this category and stronger than any brand-stated NMN purity claim here. The clearest independent credential in the lineup; only Tru Niagen's ISO/IEC-accredited batch testing is comparable.
Honestly scored as a non-NMN product. This is NR 250 mg + pterostilbene 50 mg per 2-capsule serving — clearly labeled NR, not NMN, which on a list ranking NMN matters. NR is a different precursor, one step further back in the NAD+ pathway. It loses ground here for not being NMN and for being a standard (non-enteric) 2-capsule serving, even though the formula itself is sound.
Strong. Elysium is an established longevity brand, and Basis pairs NR with pterostilbene — a deliberate, resveratrol-like polyphenol addition — in a formula studied in a placebo-controlled NAD+ trial. The trial backing and the thoughtful two-ingredient formulation signal a serious product, not a white-label commodity; among the most credible formulations in the lineup.
The weakest axis. At roughly $60 for a 30-day supply (~$2.00 per serving), it's one of the higher monthly costs here. As a pure cost proposition it loses to the budget NMN (Double Wood, #7) and the value single-ingredient NMN (Partiqlar, #4). The score reflects that the premium buys the NSF certification and trial-backed formula rather than a competitive price-per-gram.
A real edge. Because Basis is NR-based, it is NOT subject to the FDA's late-2022 position excluding NMN from the supplement category — so it lists and restocks far more reliably than the NMN picks, which face relabeling and ASIN rotation. Alongside Tru Niagen (#3), it's the most regulatorily-stable option in the lineup.
“NSF Certified for Sport.”
NSF Certified for Sport is stated on the listing and is the strongest independent-testing claim in this nine-product lineup. It verifies contents and screens for banned substances — a genuine, auditable certification and the main driver of Basis's high testing score.
“Clinically studied and shown to raise NAD+.”
Supported by a placebo-controlled trial showing the NR-plus-pterostilbene formula raises NAD+ — real human evidence that the product does something measurable. Accurate as stated, provided it's read as NAD+-raising and not over-interpreted as proof of a longevity or anti-aging outcome.
“A more stable, reliably available alternative to NMN.”
Accurate. Because Basis is NR-based, it is not subject to the FDA's NMN exclusion, so it lists and restocks far more reliably than NMN products that face relabeling and ASIN rotation. A genuine, structural availability advantage — clearly labeled here as an NR alternative, not NMN.
Basis's defining edge is NSF Certified for Sport — independent verification of contents plus banned-substance screening, a credential almost nothing else in this category carries. In a market where NMN purity and dosing are overwhelmingly brand-stated, that third-party certification is the single strongest reason a trust-focused buyer (or a drug-tested athlete) might choose Basis over a cheaper, self-disclosed NMN. It's the clearest independent credential in the lineup.
We rank Basis as an honest alternative, not as an NMN product, and the distinction is real: it's nicotinamide riboside plus pterostilbene, and NR sits one step further back in the NAD+ pathway. That's deliberate. NR is not subject to the FDA's NMN exclusion, so it sidesteps the regulatory question that makes NMN listings volatile. If you specifically want NMN, this isn't it; if you want a well-tested NAD+ booster that stays in stock, the NR route is a feature, not a compromise.
Basis is backed by a placebo-controlled trial showing it raises NAD+, which is genuinely more than the brand-stated NMN picks can show. But the broader NR literature is the honest context: Elhassan 2019 found NR raised the muscle NAD+ metabolome yet did not change mitochondrial function or physical performance. Raising NAD+ is a measurable biomarker effect; it does not reliably translate into a functional or longevity benefit. Basis has real NAD+-raising evidence — not proof it slows aging.
Everything strong about Basis comes at a price: roughly $60 for a 60-capsule bottle that lasts 30 days, one of the higher monthly costs in this ranking. The premium buys the NSF certification, the trial-backed formula and an established brand — not a competitive cost-per-gram. If certification and reliable availability are what you're optimizing for, that premium is defensible. If you're optimizing for price, the budget Double Wood (#7) or value Partiqlar (#4) are far cheaper, and Tru Niagen (#3) is the other certified-and-stable NR option to weigh.
Elysium Basis is the most-tested, most-stable option in this lineup, and it earns that on credentials: NSF Certified for Sport — a genuine independent certification almost nothing else here carries — plus a placebo-controlled trial showing it raises NAD+. Being NR-based, it sidesteps the FDA's NMN exclusion and stays reliably in stock. For a buyer who weights independent verification and dependable availability above all, it's the clearest trust play on the board. It ranks at #8 because of what it is and what it costs, both stated plainly. It's NR plus pterostilbene, not NMN — a different precursor, included as an honest alternative on a list that's primarily about NMN — and at roughly $60 for a 30-day supply it's one of the pricier picks per month. Read its evidence honestly too: it raises NAD+, a biomarker, but the broader NR literature shows that raising NAD+ doesn't reliably produce functional or longevity benefits. The call: if a real third-party certification and stable supply matter more to you than getting NMN specifically, Basis is the pick. If you want NMN, look to ProHealth (#1) or Partiqlar (#4); and if you want the other certified, reliably-stocked NR option, Tru Niagen (#3) is its closest peer.
Check Elysium · 250 mg NR + 50 mg pterostilbene (2 caps) · 60 capsules · NR alternative (not NMN) on AmazonThe other stable, heavily-studied NR alternative — patented Niagen with ISO/IEC-accredited batch testing, also free of the NMN exclusion. Choose this if you want NR from the most-researched raw material rather than the NR-plus-pterostilbene formula.
See it on the list →The credibility-forward best-overall NMN — branded, clinically-studied Uthever NMN at 500 mg, triple lab-tested. Choose this if you actually want NMN and value a branded raw material over an NR formula.
See it on the list →A different non-NMN route — a nicotinamide-based whole-system NAD+ formula with a published human trial. Choose this if you want a multi-cofactor NAD+ approach rather than a single NR-plus-pterostilbene pairing.
See it on the list →A randomized, double-blind, placebo-controlled crossover trial showed 6 weeks of NR (1,000 mg/day) was well tolerated and raised NAD+ metabolism in healthy middle-aged and older adults, with a suggestive reduction in blood pressure. Key human evidence for NR — the regulatorily-stable, better-studied NAD+ precursor that Basis is built on.
In a placebo-controlled crossover trial, 21 days of NR (1,000 mg/day) in aged men raised the muscle NAD+ metabolome and produced anti-inflammatory signatures, but did NOT change mitochondrial bioenergetics or physical performance. The honest illustration of the gap between raising NAD+ and producing a functional benefit — the core caution applied to Basis's NAD+-raising claim.
A randomized, placebo-controlled, double-blind trial found 10 weeks of oral NMN (250 mg/day) improved muscle insulin sensitivity in prediabetic women. The reference point for the NMN side of this category — included to contextualize Basis as an NR alternative, not an NMN product, and to keep the evidence framing honest across both precursors.
One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.
